Table 3.
Total patients with CRS (N = 51) | |||
---|---|---|---|
All grades | Grades 1–2 | Grades 3–4 | |
Liver | |||
ALT high | 25 (49) | 24 (47) | 1 (2) |
AST high | 40 (78) | 23 (45) | 17 (33) |
Bilirubin high | 22 (43) | 22 (43) | 0 |
Kidney | |||
Creatinine high | 18 (35) | 15 (29) | 3 (6) |
Pulmonary and vascular systems | |||
Hypotension | 12 (24) | 9 (18) | 3 (6) |
Hypoxia | 4 (8) | 4 (8) | 0 |
Respiratory failure | 1 (2) | 0 | 1 (2) |
Coagulopathya | |||
aPTT prolonged | 31 (67) | 28 (61) | 3 (7) |
Fibrinogen decreased | 17 (37) | 0 | 17 (37) |
ALT alanine aminotransferase, aPTT activated partial thromboplastin time, AST aspartate aminotransferase, CRS cytokine release syndrome
aOnly 46 patients had laboratory test results available (N = 46 was used as the denominator)